Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 9.48% is in line with its 5-year average of 10.14%, around the middle of its 5-year range (-7.15%–21.61%).
3.88% above its 12-month average of 9.13%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.11%.
NET PROFIT MARGIN
9.48%
NET PROFIT MARGIN AVG TTM
9.13%
NET PROFIT MARGIN AVG 3Y
10.23%
NET PROFIT MARGIN AVG 5Y
10.14%
NET PROFIT MARGIN AVG 10Y
9.57%
NET PROFIT MARGIN AVG 15Y
11.46%
NET PROFIT MARGIN AVG 20Y
13.45%
CURRENT VS TTM AVG
+3.88%
CURRENT VS 3Y AVG
-7.34%
CURRENT VS 5Y AVG
-6.52%
CURRENT VS 10Y AVG
-0.92%
CURRENT VS 15Y AVG
-17.28%
CURRENT VS 20Y AVG
-29.53%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+2.99%
vs the sector median at left
Zimmer Biomet Holdings, Inc.
Market Cap
$18.51B
Net Profit Margin
9.48%
TTM Avg
9.13%
3Y Avg
10.23%
5Y Avg
10.14%
Market Cap
$19.81B
Net Profit Margin
-2.79%
TTM Avg
-14.44%
3Y Avg
-3.94%
5Y Avg
-4.74%
Market Cap
$17.06B
Net Profit Margin
17.67%
TTM Avg
18.50%
3Y Avg
17.20%
5Y Avg
16.74%
Market Cap
$20.98B
Net Profit Margin
41.56%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$15.46B
Net Profit Margin
17.26%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$14.62B
Net Profit Margin
35.33%
TTM Avg
28.88%
3Y Avg
23.04%
5Y Avg
19.31%
Market Cap
$13.59B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.51B | 9.48% | 9.13% | 10.23% | 10.14% |
| Viatris Inc. (VTRS)vs › | $19.81B | -2.79% | -14.44% | -3.94% | -4.74% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.06B | 17.67% | 18.50% | 17.20% | 16.74% |
| STERIS plc (STE)vs › | $20.13B | 13.33% | 12.25% | 8.55% | 8.79% |
| United Therapeutics Corporation (UTHR)vs › | $20.98B | 41.56% | 41.73% | 40.84% | 37.71% |
| Revvity, Inc. (RVTY)vs › | $15.99B | 8.16% | 9.60% | 8.02% | 12.66% |
| Solventum Corporation (SOLV)vs › | $15.46B | 17.26% | 12.25% | 14.36% | 15.15% |
| Exelixis, Inc. (EXEL)vs › | $14.62B | 35.33% | 28.88% | 23.04% | 19.31% |
| Tempus AI, Inc. (TEM)vs › | $13.59B | -17.77% | -60.53% | -62.93% | -77.31% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.33B | -5.96% | -1.67% | 5.09% | 7.31% |
Operating Margin
15.7%
Net Profit Margin
9.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 9.11% |
| 2026-03-31 | 11.41% |
| 2025-12-31 | 6.22% |
| 2025-09-30 | 11.54% |
| 2025-06-30 | 7.36% |
| 2025-03-31 | 9.53% |
| 2024-12-31 | 11.84% |
| 2024-09-30 | 13.66% |
| 2024-06-30 | 12.50% |
| 2024-03-31 | 9.13% |
| 2023-12-31 | 21.61% |
| 2023-09-30 | 9.28% |
| 2023-06-30 | 11.21% |
| 2023-03-31 | 12.70% |
| 2022-12-31 | -7.15% |
| 2022-09-30 | 11.62% |
| 2022-06-30 | 8.63% |
| 2022-03-31 | 0.85% |
| 2021-12-31 | -4.12% |
| 2021-09-30 | 8.64% |
| 2021-06-30 | 8.05% |
| 2021-03-31 | 12.37% |
| 2020-12-31 | 16.00% |
| 2020-09-30 | 12.57% |
| 2020-06-30 | -16.85% |
| 2020-03-31 | -28.51% |
| 2019-12-31 | 15.09% |
| 2019-09-30 | 22.78% |
| 2019-06-30 | 6.72% |
| 2019-03-31 | 12.46% |
| 2018-12-31 | -43.51% |
| 2018-09-30 | 8.83% |
| 2018-06-30 | 9.21% |
| 2018-03-31 | 8.66% |
| 2017-12-31 | 59.36% |
| 2017-09-30 | 5.45% |
| 2017-06-30 | 9.45% |
| 2017-03-31 | 15.18% |
| 2016-12-31 | 3.46% |
| 2016-09-30 | 8.66% |
| 2016-06-30 | -1.62% |
| 2016-03-31 | 5.71% |
| 2015-12-31 | 6.57% |
| 2015-09-30 | 1.26% |
| 2015-06-30 | -14.87% |
| 2015-03-31 | 15.11% |
| 2014-12-31 | 12.81% |
| 2014-09-30 | 15.65% |
| 2014-06-30 | 14.92% |
| 2014-03-31 | 19.07% |
| 2013-12-31 | 19.01% |
| 2013-09-30 | 14.37% |
| 2013-06-30 | 13.01% |
| 2013-03-31 | 19.19% |
| 2012-12-31 | 12.94% |
| 2012-09-30 | 17.37% |
| 2012-06-30 | 19.07% |
| 2012-03-31 | 18.37% |
| 2011-12-31 | 13.42% |
| 2011-09-30 | 18.57% |
| 2011-06-30 | 17.92% |
| 2011-03-31 | 18.73% |
| 2010-12-31 | 3.08% |
| 2010-09-30 | 19.80% |
| 2010-06-30 | 15.65% |
| 2010-03-31 | 19.33% |
| 2009-12-31 | 14.02% |
| 2009-09-30 | 15.36% |
| 2009-06-30 | 20.60% |
| 2009-03-31 | 20.37% |
| 2008-12-31 | 16.26% |
| 2008-09-30 | 22.55% |
| 2008-06-30 | 21.04% |
| 2008-03-31 | 22.59% |
| 2007-12-31 | 24.57% |
| 2007-09-30 | 4.93% |
| 2007-06-30 | 23.85% |
| 2007-03-31 | 24.56% |
| 2006-12-31 | 26.21% |
| 2006-09-30 | 22.36% |
| 2006-06-30 | 22.79% |
| 2006-03-31 | 23.90% |
| 2005-12-31 | 23.53% |
| 2005-09-30 | 22.11% |
| 2005-06-30 | 22.52% |
| 2005-03-31 | 20.95% |
| 2004-12-31 | 24.97% |
| 2004-09-30 | 18.27% |
| 2004-06-30 | 15.77% |
| 2004-03-31 | 13.15% |
| 2003-12-31 | 5.27% |
| 2003-09-30 | 21.35% |
| 2003-06-30 | 21.65% |
| 2003-03-31 | 34.68% |
| 2002-12-31 | 19.50% |
| 2002-09-30 | 19.29% |
